Australia, Feb. 10 -- Janssen Pharmaceutica N.V., owns the trademark (2561734) for 'XAPLYTA' till June 30, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use.]
Type of Mark: Word
Date of Acceptance: Aug. 13, 2025
Registration Advertised: Feb. 9
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2561734.
Disclaimer: Curated by HT Syndication.
